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Clinical techniques and technology
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Prevenzione delle fratture mandibolari conseguenti alla necrosi ossea da difosfonati
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SummAry
mandibular fracture is usually the clinical end of bisphosphonate-related osteonecrosis of the jaw. This is a painful complication and pa-
tients cannot feed as usual, with a worsening of their quality of life. The goal of treatment in bisphosphonate related osteonecrosis of jaw 
(BronJ) patients is to slow progression of bone necrosis. We present a novel technique for treatment of severe mandibular BronJ in stage 
3 patients that present with a high risk to develop fracture, since they have a residual unaffected mandibular bone height less than 6 mm. 
We treated 10 patients in this clinical situation with an extra-oral application of a reconstructive plate superficial to the platysma, to keep 
the plate separated from the infected site to avoid contamination and consequent need of removal, followed by an intraoral approach for ac-
tive curettage of mandibular necrosis. The preservation of blood supply to the mandible and avoidance of direct contact of the infected site 
with the reconstructive plate are some advantages of this technique. This plate allows enhancement of mandibular strength, allowing proper 
treatment of the BronJ site on the oral side without fear of causing a mandibular fracture when the residual mandible is thin. This technical 
solution guarantees these patients an extended disease-free period since it is effective in preventing mandibular fractures in patients with 
low mandibular residual height left after the BronJ onset.
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riASSunTo
La frattura della mandibola rappresenta solitamente l’evento finale nei pazienti che presentano una progressione della necrosi ossea deri-
vante dall’impiego dei difosfonati. Si tratta di una grave complicanza molto dolorosa che impedisce ai pazienti di alimentarsi correttamen-
te, essendo pertanto un fattore che peggiora notevolmente la loro qualità di vita. L’obiettivo del trattamento dei pazienti che presentano la 
necrosi ossea legata ai difosfonati (BRONJ) dovrebbe essere rallentare la progressione della malattia. Presentiamo una soluzione tecnica 
per il trattamento dei pazienti che presentano necrosi mandibolare in stadio 3 ad alto rischio di sviluppare una frattura, avendo un’altezza 
mandibolare residua di osso sano inferiore a 6 mm. Il trattamento consiste nel posizionamento di una placca ricostruttiva mandibolare 
per via extra-orale in un piano superficiale al muscolo platisma per tenere i mezzi di sintesi separati dal sito infettivo e non farli contami-
nare con conseguente necessità di doverli rimuovere, seguito dal courettage per via endorale della necrosi mandibolare. Il rispetto della 
vascolarizzazione mandibolare e l’assenza di contatto diretto tra il sito di osteonecrosi e la placca ricostruttiva rappresentano alcuni dei 
vantaggi di questa metodica. La placca ricostruttiva rinforza la mandibola e consente di aggredire energicamente l’area di necrosi man-
dibolare, senza esporre il paziente a rischio di frattura iatrogena. Questo garantisce al paziente un rallentamento della progressione della 
malattia e impedisce la frattura patologica della mandibola, inevitabile epilogo delle necrosi ossee mandibolari.
PaROlE chiavE: Frattura mandibolare da difosfonati • Frattura patologica della mandibola • Stabilizzazione extra-platismatica • 
Trattamento delle necrosi ossee da difosfonati
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Introduction
mandibular fracture is usually the clinical end of bis-
phosphonate-related osteonecrosis of the jaw (BronJ). 
This situation is associated with a sudden worsening of 
patients’ quality of life, since they start experiencing pain 
and cannot eat in a normal fashion. Since at present there 
is no evidence of an effective medical or surgical therapy 
to produce complete healing of the necrotic bone, the goal 
of treatment in BronJ patients is to slow the progression 
of bone necrosis. Worsening of the pathology includes 
further fistulae formation and mandibular pathologic frac-
ture due to osteolysis extending to the inferior border.
We decided to apply a reconstructive mandibular plate 
generally used to stabilise BronJ-related mandibular 
fractures in patients who have not developed a mandibu-
lar fracture, but who are at a high risk of its development.
Since there is no literature on this topic, we arbitrarily 
selected a minimal residual thickness of unaffected man-
dibular bone of 6 mm (Fig. 1) to apply the plate on an 
extra-platysmatic dissection plane  1. When the residual 
height of normal mandibular bone is more than 6 mm, we 
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treat patients by simple curettage of the bone necrosis and 
possible removal of the sequestrum.
The proposed technique consists of the application of a 
reconstructive plate in a plane superficial to the platysma 
with an extraoral surgical access followed by an intraoral 
approach for active curettage of mandibular necrosis and 
rinsing of the surgical site. The main advantages of this 
technique are related to the maintenance of the blood sup-
ply to the mandible and avoidance of direct contact of the 
infected site with the reconstructive plate.
The position of this stable plate on a plane superficial 
to the platysma also allows the proper treatment of the 
BronJ site on the oral side, without fear of causing a 
mandibular fracture due to the surgical curettage, and can 
allow mandibular resection when clinically needed with-
out loss of occlusion.
Description of clinical technique
A sterile drape is placed over the mouth and face to 
avoid any direct contamination of the cervical field by 
the infected bone. After inducing vasoconstriction with 
1:200,000 epinephrine into the submandibular region, a 
10-cm skin incision is made ~2 cm inferior to the man-
dibular border, following its profile. The dissection plane 
is immediately over the platysma muscle, 5 cm in front 
of and 5 cm behind the site of BronJ. A 2.5-mm recon-
structive locking plate is modelled with the help of a tem-
plate and then placed superficial to the platysma. Stabili-
sation is obtained through mono-cortical locking screws 
placed a few cm from the BronJ site, under plentiful 
rinsing solution (Fig. 2). meticulous haemostasis and the 
application of an aesthetic suture completes the extra-oral 
surgical procedure.
The cervical suture is covered by a sterile-drape dressing, 
and the BronJ site is accessed through an intraoral ap-
proach with minimal to no dissection of the periosteum. 
Surgery is limited to curettage and rinsing of the residual 
bone. Rotating burs are avoided, while piezosurgical in-
strumentation is preferred. Bony sequestrum is removed 
when present.
Between 2013 and 2015 we operated on 10 patients af-
fected by BronJ of the mandible who were at risk to 
develop a mandibular fracture. Clinical data are shown in 
Table i.
All patients were discharged after 2  days, with prompt 
relief of pain and allowance of feeding. We observed 
no facial nerve lesions. After a mean follow up time of 
22.2 months, we saw no infection of plates and all means 
of fixation are stable at the time of writing. in one patient, 
after 12 months we observed local progression of disease 
that was treated by intra-oral courettage without need for 
plate removal.
Discussion
BronJ is a clinical situation first reported in the modern 
era by marx in 2003 2. other authors have observed that 
a similar disease was described 100 years earlier, in 1899 
by dearden in the British Medical Journal in workers in 
the white phosphorus mines and in match factories; this 
was known as “Phossy Jaw”. it is possible that long-term 
exposure to phosphorus in these workers induced the pre-
cipitation of bisphosphonates in bone leading to a clinical 
condition similar to the well-known BronJ.
The aetiopathological hypothesis of this disease is that 
bisphosphonates are powerful osteoclast inhibitors, and 
long-term use can result in suppression of bone turnover 
with increased trabecular bone density, inducing vascular 
insufficiency and causing bone necrosis. moreover, the 
impaired bone turnover leads to failed removal of old os-
teocytes. osteocytes are not immortal cells; thus, when 
these cells die bone necrosis occurs 3.
BronJ is a clinical situation that is observed increasingly 
frequently. The effectiveness of bisphosphonates in prevent-
ing bone pain and reabsorption in osteoporosis and control-
Fig. 2. Intraoperative view: the position of the 2.5 mm plate in the extra-
platysmatic plane.
Fig. 1. Panoramic radiograph reveals wide bone destruction in the left 
mandibular angle, with residual height less than 6 mm.
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ling bone metastasis in the oncologic population leads to 
the increased use of this therapy. BronJ is related to both 
iv and oral administration, the latter being less risky 1.
The clinical presentation of BronJ patients can differ. 
Attempting to standardise the management of these pa-
tients, the American Association of oral and maxillo-
facial Surgeons guidelines proposed a modified staging 
system in 2009  4:
• At-risk category. includes asymptomatic patients pre-
viously treated with either oral or iv bisphosphonates;
• Stage 0. no clinical evidence of necrotic bone, but non-
specific clinical findings and symptoms;
• Stage 1. exposed necrotic bone, asymptomatic, and 
with no evidence of infection;
• Stage 2. exposed and necrotic bone associated with in-
fection as evidenced by pain and erythema in the region 
of exposed bone with or without purulent drainage;
• Stage 3. exposed and necrotic bone in patients with pain, 
infection, and one or more of the following: exposed and 
necrotic bone extending beyond the region of alveolar 
bone, resulting in pathologic fracture, extraoral fistula, oro-
antral/oro-nasal communication, or osteolysis extending to 
the inferior border of the mandible or the sinus floor.
in the early stages conservative treatment is usually ad-
vised, while in approaching more complex clinical situ-
ations, as with stage 2-3  patients, the correct choice is 
challenging since management is not yet standardised. 
Surgical debridement/resection, in combination with anti-
biotic therapy, may offer a long-term palliative and valid 
solution, but progression to a more complex situation is 
more likely to occur with time.
in fact, usually the last stage is clinically characterised by 
pain, swelling, fistulae and finally mandibular fracture. in 
this situation patients cannot properly eat and, even if the 
fracture is reduced and stabilised with surgery, the frac-
ture is not likely to heal. on the contrary, the presence 
of osteosynthesis material over the fracture may sustain a 
chronic infection. 
Kuijpers et al. in 2011 5 described a unique case of sponta-
neous healing of a BronJ-related mandibular fracture in 
a 74-year-old woman, thus showing the persistent healing 
potential of bisphosphonate-treated bone, but of course 
this is not a rule.
deciding not to treat patients often means sentencing 
them to a quick decline of their quality of life because of 
the high degree of pain. in selected cases they can even 
be treated with free flap reconstruction after mandible re-
section  6, but most of these patients are old and in poor 
general condition, thus their clinical situation cannot be 
addressed with complex surgical procedures.
Therefore, we decided to stabilise the mandibular bone af-
fected by BronJ before fracture in those cases in which 
this clinical evolution is highly predictable, leading to a bet-
ter clinical situation and preventing painful complications. 
We arbitrarily decided to apply a mandibular reconstruc-
tive plate using the previously described extra-platysma 
technique  1 when the residual height of the unaffected 
mandible is no more than 6 mm (Fig. 3). The skin incision 
in the neck is set 2 cm inferior to the lower mandibular 
border to improve the aesthetic result. The presence of os-
teosynthesis material over the platysma and placement of 
the screws distant from the infected surgical site reduce 
the risks of maintenance of chronic infection and worsen-
ing of osteonecrosis.
This plate is fixed in a plane superficial to the platysma 
muscle so that surgical dissection is not dangerous for the 
facial nerve since the marginalis mandibulae branch lies 
deeper inside. however, placing the screws without direct 
vision of the nerve branch could lead to nerve injuries. 
This is rare, and has never occurred in our patients.
This technique is an application of well-known concepts 
of stabilisation of atrophic jaws, without removal of the 
periosteal support to the residual stumps; consequently, 
blood supply to the affected mandible is maintained  7. 
That is likely important for spontaneous healing of the 
necrotic bone and preventing expansion of the osteitis.
Table I. Clinical data of patients.
Patient name/gender/age Residual unaffected 
mandibular height 
(mm)




M.E./F/ 65 2 IV Multiple myeloma 36
B.M./F/56 1 IV Breast cancer metastasis 26
M.P./M/70 4 IM Paget 24
L.S./F/72 6 Oral Osteoporosis 18
G.V./F/78 6 Oral Osteoporosis 30
A.F./M/72 1 IM Melanoma metastasis 20
T.A./F/74 3 IM Breast cancer metastasis 20
L.V./M/77 5 IM Multiple Myeloma 26
A.P./F/82 4 Oral Osteoporosis 14
S.S./F/75 3 IM Osteoporosis 8
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use of copious rinsing solution when drilling the screws 
is also advised to reduce the risk of BronJ progression. 
The use of a locking instead of a compressive plate is 
important to avoid forcing of the weakened mandibular 
bone, which could lead to a mandibular fracture. The 
use of monocortical screws is intended to avoid exces-
sive mechanical stress on the bone; the use of bicorti-
cal screws could lead to overloading. The oral approach 
stage of the operation is limited to curettage and rinsing 
of the surgical site. This is usually performed trying to 
avoid round burs and using ultrasound surgical devices 
such as a piezoelectric drill.
The presence of cutaneous fistulae does not represent a 
barrier to the application of this technique. in fact, in three 
cases we removed the fistula at the time of neck skin inci-
sion, and then closed it with a lower platysma pedicled 
flap to separate the necrotic site from the dissection plane 
where the reconstructive plate was going to be positioned.
rapid relief and preservation of normal masticatory func-
tion are achieved, and patients usually recover promptly.
The technique is painless, and patients can easily eat and 
be discharged after a few days, and thus this surgical so-
lution can also be used in patients in poor general clini-
cal conditions.
The suggested technique is easy to apply and in our pa-
tients was effective in preventing mandibular fractures 
in patients with low mandibular residual height after 
BronJ onset.
References
1 Biglioli F, Pedrazzoli M. Extra-platysma fixation of bisphos-
phonate-related mandibular fractures: a suggested technical 
solution. int J oral maxillofac Surg 2013;42:611-4. 
2 marx re. Pamidronate (Aredia) and Zoledronate (Zometa) 
induced avascular necrosis of the jaws: a growing epidemic. 
J oral maxillofac Surg 2003:61:1115-8.
3 ruggiero Sl. Emerging concepts in the management and 
treatment of osteonecrosis of the jaw. oral maxillofac Surg 
Clin north Am 2013 25:1:11-20.
4 ruggiero Sl, dodson TB, Assael lA, et al. American As-
sociation of Oral and Maxillofacial Surgeons position paper 
on bisphosphonate-related osteonecrosis of the jaws--2009 
update. J oral maxillofac Surg 2009:67(Suppl 5):2-12.
5 Kuijpers Sc, van Roessel EW, van Merkesteyn JP. Unusual 
case of a conservatively treated pathological fracture after 
sequestrectomy in a patient with long-term oral bisphospho-
nate use. J Craniomaxillofac Surg 2011:39:69-72. 
6 Colletti g, Autelitano l, rabbiosi d, et al. Technical refine-
ments in mandibular reconstruction with free fibula flaps: 
outcome-oriented retrospective review of 99 cases. Acta 
otorhinolaryngol ital. 2014 oct;34(5):342-8. 
7 Ellis E iii, Price c. Treatment protocol for fractures of the 
atrophic mandible. J oral maxillofac Surg 2008:66:421-35. 
address for correspondence: Marco Pedrazzoli, via di Rudinì 8, 
20142 milan, italy. Fax. +39 02 81844704. e-mail: marcomxf@
gmail.com
received: november 8, 2015 - Accepted: February 2, 2016
Fig. 3. Postoperative panoramic radiograph (at 24 months) showing the 
stable position of the reconstructive plate and extraordinary regrowth of 
mandibular bone. 
